Literature DB >> 6193308

Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.

A K Bhan, C L DesMarais.   

Abstract

The presence of major histocompatibility antigens [HLA-A,B,C; beta 2 microglobulin (beta 2)m; la-like] on tumor cells and the nature and distribution of mononuclear cellular infiltrates in benign and malignant human breast tumors were studied by the use of monoclonal antibodies and immunoperoxidase techniques on frozen tissue sections. Although all benign tumors expressed HLA-A,B,C or beta 2m, 20 of 53 primary breast cancers did not react with anti-HLA-A,B,C or anti-beta 2m antibodies. Expression of la-like antigens was rarely encountered on tumor cells. The intensity of the inflammatory mononuclear cellular response did not correlate with the expression of HLA-A,B,C or beta 2m by the tumor cells. Most of the mononuclear cells were identified as T-cells. T-cells with a cytotoxic-suppressor phenotype (T8+) were generally the predominant cell type among those found as single cells in the tumor stroma or invading tumor nests. However, infiltration of tumor nests by lymphocytes was infrequently seen and was usually limited to the periphery of the tumor. In contrast, lymphocytes with a helper-inducer phenotype (T4+, Leu-3a+) predominated in the lymphoid aggregates. Anti-Leu-7 (HNK-1) antibody, which reacts with natural killer cells, stained only a few mononuclear cells in the cellular infiltrate in most cases of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193308

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  37 in total

1.  Alterations of class I HLA genes in human colon cancers.

Authors:  M Bar-Eli; H Battifora; M J Cline
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

2.  Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts.

Authors:  J Gogusev; B Teutsch; M T Morin; F Mongiat; F Haguenau; G Suskind; G F Rabotti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 3.  Roles of the innate immune system in mammary gland remodeling during involution.

Authors:  Kamran Atabai; Dean Sheppard; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

4.  Angiogenesis and inflammation in invasive carcinoma of the breast.

Authors:  A H Lee; L C Happerfield; L G Bobrow; R R Millis
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

5.  Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.

Authors:  F Vánky; G Stuber; S Rotstein; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Identification of lymphocyte subsets and natural killer cells in head and neck cancers. An immunohistological study using monoclonal antibodies.

Authors:  Y Harabuchi; N Yamanaka; A Kataura
Journal:  Arch Otorhinolaryngol       Date:  1985

Review 7.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 8.  Adaptive immunity programmes in breast cancer.

Authors:  Frederick S Varn; David W Mullins; Hugo Arias-Pulido; Steven Fiering; Chao Cheng
Journal:  Immunology       Date:  2016-09-20       Impact factor: 7.397

9.  New monoclonal antibodies to the T cell antigens CD4 and CD8. Production and characterization in formalin-fixed paraffin-embedded tissue.

Authors:  S L Williamson; M Steward; I Milton; A Parr; N H Piggott; A S Krajewski; B Angus; C H Horne
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes.

Authors:  K Chikamatsu; M Eura; H Matsuoka; H Murakami; T Fukiage; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.